v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net Income (Loss) $ 12,827 $ (73,003)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Stock-based compensation expense 5,159 12,023
Depreciation and amortization expense 2,135 2,979
Non-cash operating lease cost 4,109 4,780
Amortization of debt issuance costs 0 950
Loss on disposal of fixed assets 0 293
Impairment of long-lived assets 0 3,267
Change in fair value of warrant liabilities 0 (546)
Changes in operating assets and liabilities:    
Accounts receivable due from SPN - related party 1,186 0
Prepaid expenses and other current and other non-current assets 3,389 2,526
Collaboration receivable - related party 0 (9,927)
Inventories 0 (23,350)
Deferred income - related party 0 192
Accounts payable (1,887) 1,184
Accrued liabilities due to SPN - related party (4,297) 0
Operating lease liabilities (4,206) (2,261)
Accrued expenses and other current and long-term liabilities (4,794) 5,846
Net cash provided by (used in) operating activities 13,621 (75,047)
Cash flows from investing activities:    
Purchases of property and equipment (215) (161)
Sales of restricted investments 0 1,401
Net cash (used in) provided by investing activities (215) 1,240
Cash flows from financing activities:    
Proceeds from at the market equity offering, net of issuance costs 996 18,409
Issuance of common stock under ESPP 184 353
Net cash provided by financing activities 1,180 18,762
Net increase (decrease) in cash, cash equivalents, and restricted cash 14,586 (55,045)
Cash, cash equivalents and restricted cash at beginning of period 39,461 136,150
Cash, cash equivalents and restricted cash at end of period 54,047 81,105
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 7,160
Supplemental disclosure of non-cash investing and financing activities:    
Property and equipment purchases included in accounts payable and accrued expenses $ 8 $ 0